Terms: = Cervical cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
2 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome.
Gorter A; Prins F; van Diepen M; Punt S; van der Burg SH
J Transl Med; 2015 Sep; 13():295. PubMed ID: 26357849
[TBL] [Abstract] [Full Text] [Related]
